Clinical trials in Burkina Faso
247 studies list at least one site in Burkina Faso. 31 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-04.
Get an email when these change. Save the studies in Burkina Faso recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Most studied here
Who runs them
London School of Hygiene and Tropical Medicine (21) · ANRS, Emerging Infectious Diseases (17) · University of California, San Francisco (13) · Institut de Recherche en Sciences de la Sante, Burkina Faso (10) · Novartis Pharmaceuticals (10) · Institute of Tropical Medicine, Belgium (10) · GlaxoSmithKline (10) · University of Oxford (9)
What changed recently
From the registry's own updates since Oct 14, 2026.
Started recruiting1
- Effectiveness of an Alternative Protocol in the Management of Acute MalnutritionOct 23, 2026NCT06792370
Results posted1
Studies
Recruiting first, then most recently updated. Showing 50 of 247 — search for more.
- Effectiveness of an Alternative Protocol in the Management of Acute MalnutritionRecruitingNCT06792370Not applicable
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2)RecruitingNCT07811908Phase 2
- Frailty, Geriatric Syndromes and Care Pathways of Older Adults Living With HIV in West AfricaRecruitingNCT07355413
- Co-administration of Calcium and Multiple Micronutrient Supplements for Maternal and Newborn Hemoglobin and Iron StatusRecruitingNCT06568315Phase 3
- Assessing Vaccine Effectiveness of R21/Matrix-M Across Malaria Transmission Settings (AVERT)RecruitingNCT07749911
- Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina FasoNot yet recruitingNCT07730177Phase 1
- Field Trial of PfSPZ-LARC2 Vaccine in Burkinabe AdultsRecruitingNCT07385287Phase 2
- Therapeutic Recommendations For The Treatment Of Children With A RetinoblastomaRecruitingNCT04425434
- Recommendations for the Treatment of Children With Burkitt's LymphomaRecruitingNCT04425421
- Therapeutic Recommendations for NephroblastomaRecruitingNCT04423484
- Assessing the Effects of Cool Roofs on Indoor Environments and HealthRecruitingNCT06579950Not applicable
- Mother Screening for Relapse Using Mid-upper Arm Circumference Among Children Recovered From Severe Acute Malnutrition (Full Scale Trial)RecruitingNCT06599580Not applicable
- Safety of Antimalarials in the FIRst trimEsterRecruitingNCT06962319Phase 3
- Maternal Probiotic Intervention to Improve Gut Health - Trial II - Burkina Faso (MPIGH-II)RecruitingNCT07134790Phase 2
- Azithromycin as Adjunctive Treatment for Uncomplicated Severe Acute MalnutritionRecruitingNCT06010719Phase 4
- Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking AfricaRecruitingNCT03803735
- Vitality in Infants Via Azithromycin for Neonates TrialNot yet recruitingNCT05763693Phase 4
- An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria VaccineRecruitingNCT07009847
- Integrating Malaria Vaccine With Seasonal Malaria Chemoprevention in West AfricaRecruitingNCT06860178Phase 4
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum MalariaRecruitingNCT05750628Phase 2
- Continous Positive Airway Pressure (CPAP) Support for Acute Hypoxemic Respiratory Failure in Burkina FasoRecruitingNCT06912360Not applicable
- Validation and Simplification of the Retinol Isotope Dilution Technique in Burkinabe SchoolchildrenRecruitingNCT06759493
- Assessing the Effect of Cool Roofs on Health Using Smartwatches in Ouagadougou, Burkina FasoNot yet recruitingNCT06842641Not applicable
- Seasonal R21 Mass Vaccination for Malaria EliminationRecruitingNCT06578572Phase 3
- The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM)RecruitingNCT05951751Not applicable
- Description and Comparison of Biological Vulnerability in Small Vulnerable Newborns Versus Healthy Community Controls in Urban Burkina FasoRecruitingNCT05730569
- Malaria Burden in Pregnant Women and the Incidence of Pregnancy in a Cohort of NulligravidaRecruitingNCT06162078
- Microbiome-Directed Food for Sustained Recovery From Acute MalnutritionNot yet recruitingNCT05586139Not applicable
- Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina FasoRecruitingNCT05946642Phase 3
- Fermented Millet Porridge, Gut Microbiota and Inflammation Status in WomenRecruitingNCT05299970Not applicable
- SUNRISE CRT: Radio Intervention to Stimulate Early Child DevelopmentNot yet recruitingNCT05335395Not applicable
- Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum MalariaCompletedNCT05842954Phase 3
- A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 Combined With R21/Matrix-M (a "Multi-stage" Malaria Vaccine)Active, not recruitingNCT06958198Phase 1
- A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-MActive, not recruitingNCT07183371Phase 2
- A Study to Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.CompletedNCT05790889Phase 1/2
- Variants of SARS-CoV-2 Causing COVID-19 in AfricaCompletedNCT05311891
- ANRS 12372 MODERATO StudyCompletedNCT04022967Phase 3
- Infant Malaria Vaccine Schedule OptimizationActive, not recruitingNCT06879327Phase 2
- Malaria Rapid Diagnostic Tests (RDTs) in Pregnancy: Detection of Placental MalariaCompletedNCT01555255
- Demonstration of an Electronic Clinical Decision Support Module for Dengue in Burkina FasoCompletedNCT04582474Not applicable
- Safety and Immunogenicity of SUM-101 Malaria Vaccine in Children and Infants Living in Burkina FasoCompletedNCT06618885Phase 1
- Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort B1)CompletedNCT07811882Phase 2
- Dose Finding Trial of R21/Matrix-M in School ChildrenActive, not recruitingNCT07074665Phase 2
- MiMBa Pregnancy RegistryCompletedNCT04825782
- Mother Screening for Relapse Using Mid-upper Arm Circumference Among Children Recovered From Severe Acute MalnutritionCompletedNCT05932992Not applicable
- Evaluation of "C'Est La Vie!" Digital Health EducationCompletedNCT07636629Not applicable
- Immunogenicity and Tolerability of Booster Typhoid Conjugate Vaccine (TCV) 5-6 Years After Initial Dose in Children in Burkina FasoCompletedNCT07624175Phase 2
- Alternative RUTFs for Treatment of Child WastingCompletedNCT06912620Phase 3
- Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum MalariaCompletedNCT04546633Phase 2
- A Study to Evaluate the Safety, Tolerability, and Immunogenicity of the rSm-p80 + GLA-SE (SchistoShield®) Candidate Vaccine in Healthy Adults in Burkina Faso and MadagascarCompletedNCT05762393Phase 1